Until now, several studies had analyzed pancreatic juice for driver mutations such as KRAS and GNAS. 25, 26 However, it is still unclear whether these mutations are useful as markers of IPMN malignancy. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.